The efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization for primary hepatocellular carcinoma in a cohort of 487 patients

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Xie, Hui ^a,b   Wang, Huaming ^b   An, Weimin ^b   Ma, Wei ^b   Qi, Ruping ^b   Yang, Bin ^b   Liu, Chunzi ^b   Gao, Yuanzhi ^b   Xu, Beibei ^b   Wang, Wenhong ^c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BEIJING 302 HOSPITAL   (China)

^c TIANJIN UNION MEDICAL CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DOXORUBICIN; FLUOROURACIL; OXALIPLATIN;

ADULT; AGE; ARTICLE; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTHROMBIN TIME; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SURVIVAL RATE; THROMBOCYTE COUNT; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; LIVER NEOPLASMS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SURVIVAL;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84895861212     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089081     Document Type: Article

References (38)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Venook AP, Papandreou C, Furuse J, de Guevara LL (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15 Suppl 4: 5-13.
3. Lencioni R, Chen XP, Dagher L, Venook AP (2010) Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? Oncologist 15 Suppl 4: 42-52.
4. Fortune BE, Umman V, Gilliland T, Emre S (2013) Liver transplantation for hepatocellular carcinoma: a surgical perspective. J Clin Gastroenterol 47 Suppl: S37-42.
5. Rossi S, Di Stasi M, Buscarini E, Quaretti P, Garbagnati F, et al. (1996) Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 167: 759-768.
6. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P (2000) Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232: 381-391.
7. Huang GT, Lee PH, Tsang YM, Lai MY, Yang PM, et al. (2005) Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 242: 36-42.
8. N'Kontchou G, Mahamoudi A, Aout M, Ganne-Carrie N, Grando V, et al. (2009) Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 50: 1475-1483.
9. Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, et al. (2012) Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy. J Clin Gastroenterol 46: 62-70.
10. Nishigaki Y, Tomita E, Hayashi H, Suzuki Y, Iritani S, et al. (2013) Efficacy and safety of radiofrequency ablation for hepatocellular carcinoma in the caudate lobe of the liver. Hepatol Res 43: 467-474.
11. Tateishi R, Shiina S, Teratani T, Obi S, Sato S, et al. (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103: 1201-1209. (Pubitemid 40328091)
12. Maluccio MA, Covey AM, Porat LB, Schubert J, Brody LA, et al. (2008) Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 19: 862-869.
13. Wang S, Zhuang L, Meng Z (2013) Hepatocellular Carcinoma More Than 3 cm in Diameter: A Systematic Review of Transcatheter Arterial Chemoembolization Plus Percutaneous Ethanol Injection versus Transcatheter Arterial Chemoembolization Alone. ISRN Gastroenterol 2013: 526024.
14. Idee JM, Guiu B (2013) Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: A review. Crit Rev Oncol Hematol 3: 00153-00154.
15. Ni JY, Liu SS, Xu LF, Sun HL, Chen YT (2013) Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 19: 3872-3882.
16. Choi SB, Kim KS, Park YN, Choi JS, Lee WJ, et al. (2009) The efficacy of hepatic resection after neoadjuvant transarterial chemoembolization (TACE) and radiation therapy in hepatocellular carcinoma greater than 5 cm in size. J Korean Med Sci 24: 242-247.
17. Gupta S, Kobayashi S, Phongkitkarun S, Broemeling LD, Kan Z (2006) Effect of transcatheter hepatic arterial embolization on angiogenesis in an animal model. Invest Radiol 41: 516-521. (Pubitemid 44284186)
18. Georgiades CS, Hong K, Geschwind JF (2008) Radiofrequency ablation and chemoembolization for hepatocellular carcinoma. Cancer J 14: 117-122.
19. Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, et al. (2008) Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 299: 1669-1677. (Pubitemid 351519864)
20. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53: 1020-1022.
21. WHO (2013) Definition of an older or elderly person. Available: http://wwwwhoint/healthinfo/survey/ageingdefnolder/en/.
22. Seki T, Tamai T, Nakagawa T, Imamura M, Nishimura A, et al. (2000) Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 89: 1245-1251.
23. Fong Y, Sun RL, Jarnagin W, Blumgart LH (1999) An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229: 790-799; discussion 799-800.
24. Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Gardini A, et al. (2003) Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 237: 536-543. (Pubitemid 38176435)
25. Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, et al. (2001) Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234: 63-70. (Pubitemid 32619336)
26. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, et al. (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243: 321-328. (Pubitemid 43327762)
27. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, et al. (2008) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 47: 82-89. (Pubitemid 351171044)
28. Rossi S, Ravetta V, Rosa L, Ghittoni G, Viera FT, et al. (2011) Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology 53: 136-147.
29. Guan YS, He Q, Wang MQ (2012) Transcatheter arterial chemoembolization: history for more than 30 years. ISRN Gastroenterol 2012: 480650.
30. Takayasu K (2012) Transarterial chemoembolization for hepatocellular carcinoma over three decades: current progress and perspective. Jpn J Clin Oncol 42: 247-255.
31. Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, et al. (2007) Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 30: 6-25. (Pubitemid 44900485)
32. Rossi S, Garbagnati F, Lencioni R, Allgaier HP, Marchiano A, et al. (2000) Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 217: 119-126. (Pubitemid 33097587)
33. Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, et al. (1994) Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 74: 817-825. (Pubitemid 24237460)
34. Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, et al. (2009) Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology 252: 905-913.
35. Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, et al. (2013) Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 31: 426-432.
36. Kim DY, Park BJ, Kim YH, Han KH, Cho SB, et al. (2013) Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective Study. Am J Clin Oncol.
37. Kim YH, Kim do Y (2013) Yttrium-90 radioembolization for hepatocellular carcinoma: what we know and what we need to know. Oncology 84 Suppl 1: 34-39.
38. Fujimori M, Takaki H, Nakatsuka A, Uraki J, Yamanaka T, et al. (2013) Survival with up to 10-year follow-up after combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma: single-center experience. J Vasc Interv Radiol 24: 655-666.